Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. 

Biotechnology

Sensorium Therapeutics

Dick Simon

Sherry Rais

Steve Haggarty

Pranav Tadi

Michael Placzek

Jerry Rosenbaum

Jeffrey Brown

Jacob Hooker

Alex Simon

The Board Members and Directors at Sensorium Therapeutics provide strategic guidance, governance, and oversight to the company. Leveraging their extensive expertise in medicine, research, and business, they ensure the company's mission aligns with its pioneering advancements in nature-derived psychoactive medicines for mental health. They support executive decision-making, foster key partnerships, and ensure compliance with regulations to drive Sensorium’s mission of transforming mental health treatments globally.

Board Members and Directors

Research and Sciences

Leadership Team

Board Members and Directors

About

Team members

Other teams at Sensorium Therapeutics

Research and Sciences

Leadership Team